Main findings
About
Eucerin DERMOPURE CLINICAL Correcting Body Care provides 48-hour hydration¹ and targets:
• Blemishes
• Post-acne marks
Specifically designed for blemish-prone skin, this lightweight body lotion improves blemishes and marks within two weeks with a powerful combination of Salicylic Acid and patented Thiamidol. Clinically and dermatologically proven, the Eucerin DERMOPURE CLINICAL Correcting Body Care is ideal for oily, blemish-prone skin and suitable for sensitive skin.
¹ Measurement on 27 subjects, 48 hours after a single application compared to baseline.
How to Use
Main findings
What is the ideal routine to reduce blemishes and post-acne marks on the body?
What are post-acne marks (post-inflammatory hyperpigmentation or PIH for short)?
PIH is a type of hyperpigmentation of the skin that is mainly triggered by the way skin regenerates after inflammation. It can affect the face and body, typically especially UV-exposed areas, and appears as flat spots of hypercoloration. These range in color from pink to red, brown or black, depending on skin tone and the depth of hypercoloration. The root cause is increased melanin production, the pigment that defines the color of a person’s skin, which is stimulated by inflammatory factors. The blemish triggers melanocytes – the melanin-producing cells – to release excessive melanosomes (pigment granules). The excessive pigment granules darken and discolor the formerly stressed area. Once initial blemishes have subsided, spots of hypercoloration, so-called post-acne marks, can remain.
Additionally, sun exposure can aggravate PIH symptoms, darkening the affected patches and prolonging the time it takes for them to fade. Most acne-related PIH will eventually fade over time, but it can take several years or even a decade until it is fully gone*.
*Abad-Casintahan, F. et al., “Frequency and Characteristics of Acne-Related Post-Inflammatory Hyperpigmentation.” J Dermatol. 2016; 43:826–828.
How can post-acne marks be prevented?
Read also some related articles
1 Product-in-use, 160 subjects, after 4 weeks
2 Product-in-use, 160 subjects, after 4 weeks
3 Product-in-use, 160 subjects, after 8 weeks
Thiamidol, Salicylic Acid
Learn More